Dimensional Fund Advisors LP Heron Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $733,021 - $2 Million	-318,705 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $84,154 - $180,669	-18,176 Reduced 5.4%	318,705 $1.82 Million
Q4 2021 Feb 09, 2022	BUY	$8.35 - $12.6 $164,344 - $247,993	19,682 Added 6.2%	336,881 $3.08 Million
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $3.15 Million - $4.67 Million	-311,146 Reduced 49.52%	317,199 $3.39 Million
Q2 2021 Aug 12, 2021	BUY	$13.27 - $18.48 $201,186 - $280,175	15,161 Added 2.47%	628,345 $9.75 Million
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $1.26 Million - $1.81 Million	87,292 Added 16.6%	613,184 $9.94 Million
Q4 2020 Feb 25, 2021	BUY	$14.61 - $22.14 $7.68 Million - $11.6 Million	525,892 New	525,892 $11.1 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.